Filtered By:
Cancer: Gastric (Stomach) Cancer
This page shows you your search results in order of relevance.
Order by Relevance | Date
Total 75501 results found since Jan 2013.
3 Reasons Why You Should Choose to Recover from Your Eating Disorder
She cannot stop running. Her legs feel heavy, like wooden logs, and her heart is pounding so hard she feels like it will explode. She starts to feel the familiar dizziness, the edges of her vision are becoming hazy, and her knees are painfully throbbing.
Her friends applaud her dedication and say they wish that they could be so disciplined. It is not discipline or motivation that causes her to run for miles down this winding road at sunrise. The voice of anorexia is screaming in her head and demands that she keep running. She is a prisoner to her own mind.
Eating disorders are not a choice. No one would choose to lose all ...
Source: Psych Central - September 5, 2015 Category: Psychiatry Authors: Jennifer Rollin, MSW, LGSW Tags: Addictions Anorexia Bulimia Disorders Eating Disorders General Psychology Self-Esteem Anorexia Nervosa Binge Eating Disorder Body Dysmorphic Disorder Eating Disorders Association Hypergymnasia Mental Disorder Nutrition Source Type: news
Alcohol and processed meat linked to increased risk of stomach cancer
Drinking more than three alcoholic drinks a day and eating processed meat and food preserved by salting could increase the risk of stomach cancer, according to the World Cancer Research Fund International
Hide related content:
Show related content
read more
Source: Nursing in Practice - April 21, 2016 Category: Nursing Authors: Kerrie Schofield Tags: Alcohol and drugs Obesity Cancer Editor ' s pick Latest News Source Type: news
Janssen Announces U.S. FDA Approval of PONVORY ™ (ponesimod), an Oral Treatment for Adults with Relapsing Multiple Sclerosis Proven Superior to Aubagio® (teriflunomide) in Reducing Annual Relapses and Brain Lesions
TITUSVILLE, N.J. – (March 19, 2021) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) approved PONVORY™ (ponesimod), a once-daily oral selective sphingosine-1-phosphate receptor 1 (S1P1) modulator, to treat adults with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease.1,2,3 PONVORY™ offers MS patients superior efficacy in reducing annualized relapse rates compared to an established oral therapy and a proven safety profile backed by ove...
Source: Johnson and Johnson - March 19, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
FDA Approves Two New Indications for XARELTO ® (rivaroxaban) to Help Prevent and Treat Blood Clots in Pediatric Patients
RARITAN, NJ, Dec. 20, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has approved two pediatric indications for XARELTO® (rivaroxaban): the treatment of venous thromboembolism (VTE, or blood clots) and reduction in the risk of recurrent VTE in patients from birth to less than 18 years after at least five days of initial parenteral (injected or intravenous) anticoagulant treatment; and thromboprophylaxis (prevention of blood clots and blood-clot related events) in children aged two years and older with congenital heart disease who have...
Source: Johnson and Johnson - December 21, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
Janssen Presents Study Results Showing Clinical Efficacy for TREMFYA ® (guselkumab) and Long-Term Safety Profile for STELARA® (ustekinumab) for Patients Living with Inflammatory Bowel Disease at Digestive Disease Week® 2022
SPRING HOUSE, PENNSYLVANIA, May 24, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data from the Phase 2 GALAXI 1 clinical trial of TREMFYA® (guselkumab) in adult patients with moderately to severely active Crohn’s disease (CD), and from three separate long-term pooled analyses of adult patients with ulcerative colitis (UC) and CD treated with STELARA® (ustekinumab).1,2,3,4 These data are being presented as oral and poster presentations and are among 29 Janssen abstracts presented during the Digestive Disease Week® (DDW) meeting taking place in person and virtually in San Di...
Source: Johnson and Johnson - May 24, 2022 Category: Pharmaceuticals Source Type: news
Stomach Cramps – Stomach Cramps and Colon...
When we think we know what's causing our stomach cramps, we tend to sit tight and wait for them to pass. That often works, but it's important to realize that stomach cramps can also be a symptom of colon cancer.
Source: About.com Colon Cancer - August 2, 2013 Category: Cancer & Oncology Authors: coloncancer.guide at about.com Tags: health Source Type: news
Functional gastrointestinal disorders in children from low socio ‐economic status and Helicobacter pylori infection
ConclusionsFGIDs are common in low SES students. A low educational level of the household head, family history of gastric cancer. and being female are related to the development of FGIDs. In this study, no relationship between the presence of H. pylori and FGIDs was found.
Source: Child: Care, Health and Development - July 1, 2017 Category: Child Development Authors: F. Jaime, A. Villagr án, C. Hernández, M. Ortiz, C. Serrano, P. R. Harris Tags: ORIGINAL ARTICLE Source Type: research
Peganum harmala L.: A Review of Botany, Traditional Use, Phytochemistry, Pharmacology, Quality marker, and Toxicity
CONCLUSION: The botany, traditional use, phytochemistry, pharmacology, quality marker, and toxicity of P. harmala L. were reviewed in this paper. It will not only provide an important clue for further studying P. harmala L., but also supply an important theoretical basis and valuable reference for in-depth research and exploitations of this plant in the future.PMID:37350001 | DOI:10.2174/1386207326666230622164243
Source: Combinatorial Chemistry and High Throughput Screening - June 23, 2023 Category: Chemistry Authors: Ling-Na Li Source Type: research
A sharable cloud-based pancreaticoduodenectomy collaborative database for physicians: Emphasis on security and clinical rule supporting
Conclusions: The proposed system allows medical staff to collect and store clinical data in a cloud, sharing the data with other physicians in a secure manner to achieve collaboration in research.
Source: Computer Methods and Programs in Biomedicine - July 10, 2013 Category: Bioinformatics Authors: Hwan-Jeu Yu, Hong-Shiee Lai, Kuo-Hsin Chen, Hsien-Cheng Chou, Jin-Ming Wu, Sarangerel Dorjgochoo, Adilsaikhan Mendjargal, Erdenebaatar Altangerel, Yu-Wen Tien, Chih-Wen Hsueh, Feipei Lai Tags: Section III: Experiences with Methods, Systems and Programs Source Type: research
The associations of comorbidities and consumption of fruit and vegetable with quality of life among stomach cancer survivors
Stomach cancer survivors (SCS) often carry the dual burden of the cancer itself and other comorbidities; meanwhile, they are highly motivated to seek health advice about lifestyles to improve their health and ...
Source: Health and Quality of Life Outcomes - April 12, 2018 Category: International Medicine & Public Health Authors: Ji-Wei Wang, Cheng-Gang Zhang, Qing-Long Deng, Wan-Li Chen, Xian Wang and Jin-Ming Yu Tags: Research Source Type: research
MTMR2 promotes invasion and metastasis of gastric cancer via inactivating IFN γ/STAT1 signaling
The aberrant expression of myotubularin-related protein 2 (MTMR2) has been found in some cancers, but little is known about the roles and clinical relevance. The present study aimed to investigate the roles an...
Source: Journal of Experimental and Clinical Cancer Research - May 21, 2019 Category: Cancer & Oncology Authors: Lei Jiang, Jun-yan Liu, Yan Shi, Bo Tang, Tao He, Jia-jia Liu, Jun-yan Fan, Bin Wu, Xian-hui Xu, Yong-liang Zhao, Feng Qian, You-hong Cui and Pei-wu Yu Tags: Research Source Type: research
Procyanidin B2 induces apoptosis and autophagy in gastric cancer cells by inhibiting Akt/mTOR signaling pathway
Procyanidin B2 (PB2), a unique component of the grape seed and other medicinal plants. PB2 has shown wide anticancer activity in various human cancer cells. However, it remains unclear about the biological eff...
Source: BMC Complementary and Alternative Medicine - February 24, 2021 Category: Complementary Medicine Authors: Yuqin Li, Xiaolan Lu, Peiying Tian, Kai Wang and Jianping Shi Tags: Research article Source Type: research
Microbial-Driven Immunological Memory and Its Potential Role in Microbiome Editing for the Prevention of Colorectal Cancer
Over the last several years, many advances have been made in understanding the role of bacteria in the pathogenesis of gastrointestinal cancers. Beginning with Helicobacter pylori being recognized as the first bacterial carcinogen and the causative agent of most gastric cancers, more recent studies have examined the role of enteric microbes in colorectal cancer. In the digestive tract, these communities are numerous and have a complex interrelationship with local immune/inflammatory responses that impact the health of the host. As modifying the microbiome in the stomach has decreased the risk of gastric cancer, modifying t...
Source: Frontiers in cellular and infection microbiology - November 12, 2021 Category: Microbiology Source Type: research
